Vertex Pharmaceuticals Overview
Vertex Pharmaceuticals Target Price
Analysts' 12-month price predictions for VRTX.
Share Price
$400.16
Average Target Price
$450.00
12.5% upside
12.5% upside2 analysts in the last 4 months
High: $462 | Low: $438
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-11 | H.C. WainwrightAndrew Fein | $462 | 15.5% upside |  |
| 2024-04-11 | Evercore ISILiisa Bayko | $438 | 9.5% upside | |
| 2023-02-08 | Morgan Stanley | $285 |  28.8% downside | |
| 2023-02-08 | H.C. Wainwright | $326 | 18.5% downside | |
| 2023-02-08 | Leerink Partners | $365 | 8.8% downside | |
| 2022-11-17 | Argus Research | $340 | 15% downside | |
| 2022-08-08 | Morgan Stanley | $253 | 36.8% downside | |
| 2022-08-05 | H.C. Wainwright | $300 | 25% downside | |
| 2022-07-12 | Cantor FitzgeraldOlivia Brayer | $365 | 8.8% downside | |
| 2022-07-11 | Stifel NicolausPaul Matteis | $240 | 40% downside | |
| 2022-07-02 | Argus ResearchJasper Hellweg | $280 | 30% downside | |
| 2022-06-13 | Cowen & Co. | $310 | 22.5% downside | |
| 2022-05-03 | Morgan StanleyMatthew Harrison | $250 | 37.5% downside | |
| 2022-04-22 | Piper Sandler | $249 | 37.8% downside | |
| 2022-04-06 | OppenheimerHartaj Singh | $350 | 12.5% downside | |
| 2022-03-22 | BMO CapitalEvan Seigerman | $274 | 31.5% downside | |
| 2022-03-22 | Robert W. BairdBrian Skorney | $240 | 40% downside | |
| 2022-01-27 | JefferiesMichael Yee | $275 | 31.3% downside | |
| 2022-01-27 | J.P. MorganCory Kasimov | $288 | 28% downside | |
| 2022-01-27 | Morgan StanleyMatthew Harrison | $208 | 48% downside | |
| 2022-01-27 | Wolfe ResearchAndrew Galler | $282 | 29.5% downside | |
| 2022-01-24 | Cowen & Co.Phil Nadeau | $300 | 25% downside | |
| 2021-12-02 | Leerink PartnersGeoff Porges | $175 | 56.3% downside | |
| 2021-12-01 | GuggenheimDebjit Chattopadhyay | $286 | 28.5% downside | |
| 2021-11-02 | Bank of America SecuritiesGeoff Meacham | $275 | 31.3% downside | |
| 2021-06-11 | BarclaysGena Wang | $285 | 28.8% downside | |
| 2021-06-11 | Cantor FitzgeraldAlethia Young | $281 | 29.8% downside | |
| 2021-05-12 | UBSColin Bristow | $279 | 30.3% downside | |